DK4038063T3 - Heterocykliske forbindelser til inhibering af tyk2-aktiviteter - Google Patents
Heterocykliske forbindelser til inhibering af tyk2-aktiviteter Download PDFInfo
- Publication number
- DK4038063T3 DK4038063T3 DK21768449.7T DK21768449T DK4038063T3 DK 4038063 T3 DK4038063 T3 DK 4038063T3 DK 21768449 T DK21768449 T DK 21768449T DK 4038063 T3 DK4038063 T3 DK 4038063T3
- Authority
- DK
- Denmark
- Prior art keywords
- activities
- heterocyclic compounds
- inhibiting tyk2
- tyk2
- inhibiting
- Prior art date
Links
- 101000844245 Homo sapiens Non-receptor tyrosine-protein kinase TYK2 Proteins 0.000 title 1
- 102100032028 Non-receptor tyrosine-protein kinase TYK2 Human genes 0.000 title 1
- 230000000694 effects Effects 0.000 title 1
- 150000002391 heterocyclic compounds Chemical class 0.000 title 1
- 230000002401 inhibitory effect Effects 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202062988317P | 2020-03-11 | 2020-03-11 | |
| PCT/CN2021/079752 WO2021180072A1 (en) | 2020-03-11 | 2021-03-09 | Heterocyclic compounds for inhibiting tyk2 activities |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK4038063T3 true DK4038063T3 (da) | 2024-05-21 |
Family
ID=77670450
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK21768449.7T DK4038063T3 (da) | 2020-03-11 | 2021-03-09 | Heterocykliske forbindelser til inhibering af tyk2-aktiviteter |
Country Status (20)
| Country | Link |
|---|---|
| US (1) | US11578058B2 (da) |
| EP (1) | EP4038063B1 (da) |
| JP (1) | JP2023524361A (da) |
| KR (1) | KR20220152303A (da) |
| CN (1) | CN114650990B (da) |
| AU (1) | AU2021234496A1 (da) |
| BR (1) | BR112022017440A2 (da) |
| CA (1) | CA3170773A1 (da) |
| DK (1) | DK4038063T3 (da) |
| ES (1) | ES2981764T3 (da) |
| FI (1) | FI4038063T3 (da) |
| HR (1) | HRP20240643T1 (da) |
| LT (1) | LT4038063T (da) |
| MX (1) | MX2022011297A (da) |
| PL (1) | PL4038063T3 (da) |
| PT (1) | PT4038063T (da) |
| RS (1) | RS65506B1 (da) |
| SI (1) | SI4038063T1 (da) |
| TW (1) | TW202144335A (da) |
| WO (1) | WO2021180072A1 (da) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2023009682A (es) | 2021-02-19 | 2023-10-30 | Sudo Biosciences Ltd | Inhibidores de tyk2 y sus usos. |
| WO2022175752A1 (en) | 2021-02-19 | 2022-08-25 | Sudo Biosciences Limited | Tyk2 inhibitors and uses thereof |
| CN117136058A (zh) * | 2021-05-04 | 2023-11-28 | 上海喆邺生物科技有限公司 | 一类含氮杂环吡啶类化合物 |
| AU2022378463A1 (en) | 2021-10-25 | 2024-05-09 | Kymera Therapeutics, Inc. | Tyk2 degraders and uses thereof |
| CN118401516A (zh) * | 2021-12-16 | 2024-07-26 | 凌科药业(杭州)有限公司 | Tyk2抑制剂及其组合物和方法 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MA38072A1 (fr) * | 2012-11-08 | 2016-07-29 | Bristol Myers Squibb Co | Composés hétérocycliques substitués par amide, utiles comme modulateurs d'il-12, il-23 et/ou de réponses à l'ifn? |
| TWI582077B (zh) * | 2013-11-07 | 2017-05-11 | 必治妥美雅史谷比公司 | 作爲ＩＬ－１２、ＩＬ－２３及／或ＩＦＮα反應調節劑之經烷基－醯胺取代之吡啶化合物 |
| CN106187910A (zh) * | 2016-07-07 | 2016-12-07 | 浙江大学 | 哒嗪类衍生物及其制备方法和用途 |
| JP7485609B2 (ja) * | 2018-03-22 | 2024-05-16 | ブリストル－マイヤーズ スクイブ カンパニー | ＩＬ－１２、ＩＬ－２３および／またはＩＦＮα応答のモジュレーターとして有用なピリジン含有ヘテロ環式化合物 |
| CN110818641B (zh) * | 2018-08-07 | 2022-10-14 | 北京诺诚健华医药科技有限公司 | 哒嗪-3-甲酰胺类化合物、其制备方法及其在医药学上的应用 |
| AU2019364336B2 (en) * | 2018-10-22 | 2023-11-16 | Alumis Inc. | TYK2 inhibitors and uses thereof |
| JP2022524279A (ja) * | 2019-01-28 | 2022-05-02 | 江▲蘇▼豪森▲薬▼▲業▼集▲団▼有限公司 | ピリダジン系誘導体阻害剤、その製造方法及び使用 |
| CN111484480B (zh) * | 2019-01-29 | 2023-08-11 | 上海翰森生物医药科技有限公司 | 一种多环类衍生物抑制剂、其制备方法和应用 |
-
2021
- 2021-03-09 HR HRP20240643TT patent/HRP20240643T1/hr unknown
- 2021-03-09 SI SI202130147T patent/SI4038063T1/sl unknown
- 2021-03-09 KR KR1020227035138A patent/KR20220152303A/ko active Search and Examination
- 2021-03-09 LT LTEPPCT/CN2021/079752T patent/LT4038063T/lt unknown
- 2021-03-09 RS RS20240542A patent/RS65506B1/sr unknown
- 2021-03-09 PT PT217684497T patent/PT4038063T/pt unknown
- 2021-03-09 MX MX2022011297A patent/MX2022011297A/es unknown
- 2021-03-09 CN CN202180006278.8A patent/CN114650990B/zh active Active
- 2021-03-09 FI FIEP21768449.7T patent/FI4038063T3/fi active
- 2021-03-09 PL PL21768449.7T patent/PL4038063T3/pl unknown
- 2021-03-09 ES ES21768449T patent/ES2981764T3/es active Active
- 2021-03-09 DK DK21768449.7T patent/DK4038063T3/da active
- 2021-03-09 AU AU2021234496A patent/AU2021234496A1/en active Pending
- 2021-03-09 EP EP21768449.7A patent/EP4038063B1/en active Active
- 2021-03-09 BR BR112022017440A patent/BR112022017440A2/pt unknown
- 2021-03-09 JP JP2022554545A patent/JP2023524361A/ja active Pending
- 2021-03-09 WO PCT/CN2021/079752 patent/WO2021180072A1/en active Application Filing
- 2021-03-09 CA CA3170773A patent/CA3170773A1/en active Pending
- 2021-03-10 TW TW110108549A patent/TW202144335A/zh unknown
-
2022
- 2022-05-04 US US17/736,866 patent/US11578058B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| LT4038063T (lt) | 2024-06-10 |
| ES2981764T3 (es) | 2024-10-10 |
| EP4038063A4 (en) | 2022-11-23 |
| TW202144335A (zh) | 2021-12-01 |
| FI4038063T3 (fi) | 2024-05-24 |
| CN114650990A (zh) | 2022-06-21 |
| RS65506B1 (sr) | 2024-06-28 |
| SI4038063T1 (sl) | 2024-06-28 |
| MX2022011297A (es) | 2022-10-07 |
| PL4038063T3 (pl) | 2024-07-15 |
| US11578058B2 (en) | 2023-02-14 |
| CN114650990B (zh) | 2023-02-03 |
| WO2021180072A1 (en) | 2021-09-16 |
| PT4038063T (pt) | 2024-05-22 |
| JP2023524361A (ja) | 2023-06-12 |
| BR112022017440A2 (pt) | 2022-10-18 |
| KR20220152303A (ko) | 2022-11-15 |
| EP4038063B1 (en) | 2024-04-24 |
| EP4038063A1 (en) | 2022-08-10 |
| US20220259184A1 (en) | 2022-08-18 |
| AU2021234496A1 (en) | 2022-10-20 |
| HRP20240643T1 (hr) | 2024-08-02 |
| CA3170773A1 (en) | 2021-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK4038063T3 (da) | Heterocykliske forbindelser til inhibering af tyk2-aktiviteter | |
| IL276509A (en) | Heterocyclic compounds as kinase inhibitors | |
| DK3704120T3 (da) | Heterocykliske forbindelser som prmt5-inhibitorer | |
| DK3684767T3 (da) | Heterocykliske forbindelser som pad-inhibitorer | |
| DK3442980T3 (da) | Heterocykliske forbindelser som ret-kinase-hæmmere | |
| DK3555070T3 (da) | Aminsubstituerede, heterocykliske forbindelser som ehmt2-hæmmere og fremgangsmåder til anvendelse deraf | |
| DK3837263T3 (da) | Nye heterocykliske forbindelser som monoacylglycerollipasehæmmere | |
| DK3883936T3 (da) | Nye heterocykliske forbindelser | |
| CL2021000361A1 (es) | Nuevos compuestos heterocíclicos como inhibidores de monoacilglicerol lipasa | |
| IL290508A (en) | Heterocyclic compounds as kinase inhibitors | |
| DK3371190T3 (da) | Heterocykliske forbindelser som pi3k-gamma-inhibitorer | |
| DK3551625T3 (da) | Heterocykliske inhibitorer af mct4 | |
| DK3672965T3 (da) | Pyramidinforbindelse som Jak-kinase-inhibitor | |
| SG11202013016YA (en) | Heterocyclic compounds as trk inhibitors | |
| IL308421A (en) | substituted heterocyclic compounds | |
| DK3762368T3 (da) | Aminopyrazindiolforbindelser som pi3k-y-inhibitorer | |
| DK3655646T3 (da) | Fremgangsmåde til beskyttelse af et leje | |
| DK3692039T3 (da) | Enantiomerer af substituerede thiazoler som antivirale forbindelser | |
| IL289389A (en) | Heterocyclic compounds as kinase inhibitors | |
| IL299664A (en) | Heterocyclic compounds | |
| DK3390407T3 (da) | Fremgangsmåder til fremstilling af heterocykliske 1,3-benzodioxolforbindelser | |
| DK3826982T3 (da) | Anvendelse af en substitueret thiazolidinforbindelse som nitrificeringshæmmer | |
| DK3833665T3 (da) | Diazabicyclooctanoner som hæmmere af serin-beta-lactamaser | |
| DK3339387T3 (da) | Forbindelser på basis af addukter med isocyanater til belægningssammensætninger | |
| DK3323811T3 (da) | Fremgangsmåde til fremstilling af en nitrogen-holdig heterocyklisk forbindelse og mellemprodukt af den nitrogen-holdige heterocykliske forbindelse |